𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Use of sirolimus-eluting coronary stents in routine clinical practice

✍ Scribed by Jean-Jacques Goy; Philip Urban; Charles Seydoux; Edoardo De Benedetti; Jean-Christophe Stauffer

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
50 KB
Volume
62
Category
Article
ISSN
1522-1946

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Incidence and clinical impact of coronar
Incidence and clinical impact of coronary stent fracture after sirolimus-eluting stent implantation
✍ Jiro Aoki; Gaku Nakazawa; Kengo Tanabe; Angela Hoye; Hirosada Yamamoto; Tomohiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Abstract Background: Stent fracture is one of the possible causes of restenosis after sirolimus‐eluting stents (SES) implantation. The aim of our study was to evaluate the prevalence and clinical impact of coronary stent fracture after SES implantation. Methods: From our prospective institutiona

Impact of three or more sirolimus-elutin
Impact of three or more sirolimus-eluting stents versus paclitaxel-eluting stents on clinical outcomes in patients undergoing percutaneous coronary intervention
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with ≥3 sirolimus‐eluting stents (SES) when compared with those treated with ≥3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s

Selective versus exclusive use of siroli
Selective versus exclusive use of sirolimus-eluting stent implantation in multivessel coronary artery disease
✍ William W. Chu; Seung-Woon Rha; Pramod K. Kuchulakanti; Edouard Cheneau; Rebecca 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 1 views

Sirolimus-eluting stents (SESs; Cypher) have demonstrated a significant reduction in restenosis rates when compared to bare metal stents (BMSs). The purpose of this study was to evaluate the strategy of exclusive use of two SESs versus the combination of one BMS and one SES for two-vessel coronary a

Comparison of sirolimus-eluting stent, p
Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions
✍ Young-Hak Kim; Seong-Wook Park; Cheol Whan Lee; Myeong-Ki Hong; Hyeon-Cheol Gwon 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Abstract Objective: This study compared the efficacy of the sirolimus‐eluting stent (SES), the paclitaxel‐eluting stent (PES), and the bare metal stent (BMS) for long coronary lesions. Background: The outcome of drug‐eluting stent (DES) implantation in long coronary lesions remains unclear. Meth

Five-year clinical outcomes of sirolimus
Five-year clinical outcomes of sirolimus-eluting versus paclitaxel-eluting stents in high-risk patients
✍ K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract Objectives and Background: First generation drug‐eluting stents have shown differential efficacy in high‐risk patient subsets at one year. It is unclear whether these differences endure over the medium‐ to long‐term. We compared the five‐year clinical efficacy and safety of sirolimus‐el